NU-MED PLUS, INC. (NUMD) Return on equity 2017–2020
NU-MED PLUS, INC. (NUMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-429.5%FY2020 · since FY2017: 5241.6% → -429.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -429.5% | — |
| FY2018 | -2449.9% | -7691.5 pp |
| FY2017 | 5241.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice